指南与共识疼痛医学区域麻醉与超声

多学会多专业共识:小关节与骶髂关节疼痛的糖皮质激素注射建议

Multisociety multispecialty consensus recommendations on corticosteroid injections for facet joint and sacroiliac joint pain.
指南 / 共识 · Reg Anesth Pain Med · 2026-01-27

该共识由多学会参与,采用改良Delphi流程制定小关节与骶髂关节糖皮质激素注射的安全使用建议。推荐小关节内注射激素可缓解疼痛改善功能,关节内、关节外或联合给药对骶髂关节注射有效;小关节10mg甲泼尼龙或曲安奈德、骶髂关节40mg或等效剂量是合理的。

要点

  • 小关节内注射激素可缓解关节炎症患者的疼痛并改善功能。
  • 骶髂关节注射时关节内、关节外或联合给药均有效。
  • 小关节10mg、骶髂关节40mg甲泼尼龙或曲安奈德或等效剂量合理。

核心结论

  • 共识提供了小关节与骶髂关节糖皮质激素注射的推荐,包括最佳剂量、重复注射间隔和标准。

研究设计与样本

  • 由美国区域麻醉与疼痛医学学会理事会及其他参与学会批准,专家进行文献综述并起草声明,采用改良Delphi流程经四轮讨论达成共识(>75%同意)。

主要发现

  • 小关节内注射糖皮质激素可缓解关节炎症患者的疼痛并改善功能。
  • 骶髂关节注射时关节内、关节外(关节周围)及联合给药均有效。
  • 无剂量-反应研究,但小关节每关节10mg甲泼尼龙或曲安奈德、骶髂关节40mg(或各自药理学等效剂量)是合理的。

关键数值与推荐

  • 所有声明和推荐经四轮讨论后由所有参与者批准。
  • 参与学会的实践指南委员会和理事会也批准了所有声明和推荐。
  • 小关节注射剂量:10mg甲泼尼龙或曲安奈德每关节;骶髂关节注射剂量:40mg(或药理学等效剂量)。

临床怎么用

  • 临床可依据共识推荐,在小关节和骶髂关节疼痛患者中安全使用糖皮质激素注射,参考推荐剂量和重复注射标准。

局限性

  • 无剂量-反应研究,最佳剂量基于共识而非剂量探索证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Corticosteroid injections (CSIs) are widely employed in facet and sacroiliac joint pain. Similar to CSIs at other sites (peripheral nerve blocks, joints, epidural), these injections are associated with potential adverse events. These multisociety consensus recommendations aim to develop evidence-based statements and recommendations on the safe use of CSIs in facet joint and sacroiliac joint injections. METHODS: Development of the consensus recommendations was approved by the American Society of Regional Anesthesia and Pain Medicine Board of Directors and several other societies that agreed to participate. The scope of statements and recommendations was agreed on to include safety of the injection technique (landmark-guided, ultrasound, or radiology-aided injections); effect of the addition of the corticosteroid on effectiveness (vs local anesthetic or saline); and adverse events related to the injection. Experts were assigned topics to perform a comprehensive literature review and draft statements and recommendations, which were refined and voted for consensus (>75% agreement) using a modified Delphi process. A modified version of the US Preventive Services Task Force grading of evidence and strength of recommendation was followed. RESULTS: All statements and recommendations were approved by all participants after four rounds of discussion. The Practice Guidelines Committees and Boards of Directors of the participating societies also approved all statements and recommendations. Injection of corticosteroid into the facet joint in patients with joint inflammation may relieve pain and improves function. Intra-articular, extra-articular (periarticular), and combined administration are effective for sacroiliac joint injections. No dose-response studies exist, but CSIs containing 10 mg of methylprednisolone or triamcinolone per facet joint and 40 mg per sacroiliac joint (SIJ) (or their respective pharmacologic equivalents) are reasonable. CONCLUSIONS: In this practice recommendation, we provide statements and recommendations on facet and sacroiliac joint CSIs, the optimal doses, and intervals and criteria for repeating the CSIs in patients with facet joint and sacroiliac joint pain.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Benzon HT, Doshi TL, Maus T, et al. Multisociety multispecialty consensus recommendations on corticosteroid injections for facet joint and sacroiliac joint pain. Reg Anesth Pain Med. 2026. PMID: 41571428. doi:10.1136/rapm-2025-107347

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。